» Articles » PMID: 30087517

Clinical Assessment and Management of Portal Hypertension

Overview
Specialty Radiology
Date 2018 Aug 9
PMID 30087517
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The development of portal hypertension in a patient with cirrhosis portends a poor prognosis. Untreated or progressive portal hypertension has serious clinical outcomes, which are often fatal. It is important to recognize portal hypertension early to delay progression and to treat complications of portal hypertension as they arise. This review will focus on the clinical assessment and management of portal hypertension.

Citing Articles

Platelet Count to Prothrombin Time: A Noninvasive Predictor of Esophageal Varices in Patients With Chronic Liver Disease.

Rizvi S, Wallam M, Siddiqui A, Haqqi S, Farrukh Z, Niaz S Cureus. 2024; 16(5):e59627.

PMID: 38832148 PMC: 11145925. DOI: 10.7759/cureus.59627.


Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week.

Pitton M, Weinmann A, Kloeckner R, Mittler J, Ruckes C, Duber C Cardiovasc Intervent Radiol. 2021; 45(1):102-111.

PMID: 34853873 PMC: 8716358. DOI: 10.1007/s00270-021-03003-z.


Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution.

Costanzo D, Bindi M, Ghinolfi D, Esposito M, Corradi F, Forfori F BMC Anesthesiol. 2020; 20(1):31.

PMID: 32000668 PMC: 6993414. DOI: 10.1186/s12871-020-0945-x.

References
1.
Vizzutti F, Arena U, Romanelli R, Rega L, Foschi M, Colagrande S . Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007; 45(5):1290-7. DOI: 10.1002/hep.21665. View

2.
Strauss E, Tramote R, Silva E, Caly W, Honain N, Maffei R . Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology. 1992; 39(6):542-5. View

3.
Berzigotti A, Seijo S, Arena U, Abraldes J, Vizzutti F, Garcia-Pagan J . Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2012; 144(1):102-111.e1. DOI: 10.1053/j.gastro.2012.10.001. View

4.
Qamar A, Grace N, Groszmann R, Garcia-Tsao G, Bosch J, Burroughs A . Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology. 2007; 47(1):153-9. DOI: 10.1002/hep.21941. View

5.
Bolognesi M, Di Pascoli M, Sacerdoti D . Clinical role of non-invasive assessment of portal hypertension. World J Gastroenterol. 2017; 23(1):1-10. PMC: 5221271. DOI: 10.3748/wjg.v23.i1.1. View